USPTO serial 77636854
ADIPOGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 22, 2012
- Examiner
- CARL III, FRED
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with ADIPOGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Yeonsu-gu Incheon, KP
Yeonsu-gu Incheon, KP
SAN DIEGO, CA
Seoul 136-701, KR
SAN DIEGO, CA
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays for research purposes; Biochemical proteins, enzymes and antibodies for scientific and medical research; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, polypeptides for in vitro research use; Biochemicals, namely, polyclonal and monoclonal antibodies for in vitro scientific or research use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting enzymes and proteins for laboratory or research use; Chemicals for use in the purification of proteins for in vitro use; Diagnostic kits for research and in vitro use consisting primarily of polyclonal and monoclonal antibodies, buffers [, and reagents ] to monitor proteins and reagents; Diagnostics, namely, diagnostic preparations and reagents other than for medical or veterinary purposes; Diagnostic preparations and reagents for scientific or research use; Diagnostic preparations and reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Protein arrays and nucleotide arrays for scientific and medical research; Reagent for chemical analyses; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Stem cells and stem cell reagents for research purposes; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for laboratory or research use; Testing kits containing peptide substrates used in analyzing and detecting proteins, enzymes and receptors for clinical or medical laboratory use | ACTIVE | Nov 1, 2009 |
| 005 | Biological preparations for medical purposes; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of polyclonal and monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Diagnostic reagents for medicinal use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of obesity and diabetes and inflammatory disorders, for use in angiogenesis, dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders [ ; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and natural medicinal extracts derived from animal, plant and microorganism sources for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, obesity and diabetes, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Reagents and media for medical and veterinary diagnostic purposes ] | ACTIVE | Nov 1, 2009 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AdipoGen Incorporation
- Other trademarks owned by AdipoGen Incorporation
- Other trademarks owned by ADIPOGEN LIFE SCIENCES, INC.
- Other trademarks owned by AdipoGen Incorporation
- Other trademarks owned by ADIPOGEN INTERNATIONAL, INC.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named ADIPOGEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 31, 2022 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| May 31, 2022 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| May 31, 2022 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| May 26, 2022 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Sep 9, 2021 | PUM1 | OFFICE ACTION ISSUED POU1 | — |
| Sep 9, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 24, 2021 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| May 22, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| May 24, 2018 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| May 24, 2018 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| May 24, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 10, 2018 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Aug 9, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 22, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Feb 12, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| May 22, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 17, 2012 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 16, 2012 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Apr 13, 2012 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 30, 2012 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 28, 2012 | IUAF | USE AMENDMENT FILED | — |
| Mar 28, 2012 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 20, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 19, 2011 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 5, 2011 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 5, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 2, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 1, 2011 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 28, 2011 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 28, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 13, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 13, 2010 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2010 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 12, 2010 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 24, 2010 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 24, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 7, 2010 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 5, 2010 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 5, 2010 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 5, 2010 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 4, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 4, 2009 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 9, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 14, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 24, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jun 9, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 9, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 7, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 7, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 7, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 7, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 24, 2008 | MPMK | NOTICE OF PSEUDO MARK MAILED | — |
| Dec 23, 2008 | NWAP | NEW APPLICATION ENTERED | — |